Quince Therapeutics to Participate at Upcoming Investor Conferences

QNCX 10.14.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-10-17
Name of Upcoming Event:2024 Maxim Healthcare Virtual Summit
Date of Upcoming Event:2024-10-29
Name of Upcoming Event:LD Micro Main Event XVII
Date of Upcoming Event:2024-10-30
Name of Upcoming Event:ThinkEquity Conference 2024
Full Press ReleaseSEC FilingsOur QNCX Tweets

About Gravity Analytica

Recent News

  • 12.18.2024 - Kumaraguru Raja, Ph.D., MBA
  • 11.13.2024 - Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
  • 11.12.2024 - Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research

Recent Filings

  • 01.08.2025 - 4 Statement of changes in beneficial ownership of securities
  • 12.27.2024 - 424B5 Prospectus [Rule 424(b)(5)]
  • 12.26.2024 - EFFECT Notice of Effectiveness

Quince Therapeutics to Participate at Upcoming Investor Conferences

October 14, 2024
PDF Version

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 14, 2024--Quince Therapeutics, Inc.(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that management will present at three upcoming investor conferences:

  • 2024 Maxim Healthcare Virtual Summit – Quince’s Chief Executive Officer and Chief Medical OfficerDirk Thye, M.D., will participate in a fireside chat onThursday, October 17, 2024beginning at3:00 p.m. Eastern Time. Qualified investors can registerhereto access the live event.
  • LD Micro Main Event XVII – Quince’s Chief Operating Officer and Chief Business OfficerBrendan Hannahwill present a company overview onTuesday, October 29, 2024beginning at6:30 p.m. Eastern Time. Please registerhereto access the live presentation.
  • The ThinkEquity Conference2024 – Quince’s PresidentCharles Ryan, J.D., Ph.D., will present a company overview onOctober 30, 2024beginning at3:00 p.m. Eastern Time. A webcast of the presentation will be accessiblehereon the Events page of Quince’s Investor Relations website.

AboutQuince Therapeutics

Quince Therapeutics(Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases. For more information on the company and its latest news, visitwww.quincetx.comand followQuince Therapeuticson social media platformsLinkedIn,Facebook,X, andYouTube.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241014846322/en/

Media & Investor Contact:Stacy RoughanQuince Therapeutics, Inc.Vice President,Corporate Communications & Investor Relationsir@quincetx.com

Source:Quince Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com